Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.

Combination therapy is more effective for prostate volumes over 60 ml.

Lygodium japonicum may help treat benign prostatic hyperplasia.

Terazosin hydrochloride helps with BPH and blood pressure, but not more than the control.

Serenoa repens is a common and effective plant-based treatment for mild-to-moderate prostate enlargement symptoms.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Finasteride significantly reduces the risk of prostate cancer.

Excessive pre-ejaculation can be treated with certain medications.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Finasteride significantly reduces prostate cancer risk.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

COVID-19 worsens urinary symptoms in men with benign prostatic hyperplasia, requiring careful treatment management.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Generic drugs for benign prostatic hyperplasia can cost up to 500% more at chain pharmacies compared to independent ones.

There is no link between hair loss and prostate enlargement.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Low-dose finasteride can cause painful breast enlargement in men, which resolves after stopping the medication.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.